Home
VERU
VERU News

Latest Veru Inc. (VERU) News on November 22, 2025

Veru to Present Two Abstracts at ObesityWeek 2025

GlobeNewswire

22 days ago

Veru to Present Two Abstracts at ObesityWeek 2025

Veru Announces Pricing of $25 Million Public Offering

GlobeNewswire

23 days ago

Veru Announces Pricing of $25 Million Public Offering

MT Newswires

23 days ago

Top Premarket Decliners

Veru Announces Proposed Public Offering

GlobeNewswire

23 days ago

Veru Announces Proposed Public Offering

October 2025's Noteworthy Penny Stocks

Simply Wall St.

a month ago

October 2025's Noteworthy Penny Stocks

Veru And Two Other Penny Stocks To Consider

Simply Wall St.

5 months ago

Veru And Two Other Penny Stocks To Consider

Veru Reports Positive Results from Phase 2b QUALITY and Maintenance Extension Study Showing Enobosarm Significantly Reduced Body Weight Regain, Prevented Fat Regain, and Preserved Lean Mass After Semaglutide Discontinuation

GlobeNewswire

5 months ago

Veru Reports Positive Results from Phase 2b QUALITY and Maintenance Extension Study Showing Enobosarm Significantly Reduced Body Weight Regain, Prevented Fat Regain, and Preserved Lean Mass After Semaglutide Discontinuation

One Veru Insider Raised Stake By 150% In Previous Year

Simply Wall St.

5 months ago

One Veru Insider Raised Stake By 150% In Previous Year

Veru to Participate in the Virtual BTIG Obesity Health Forum

GlobeNewswire

5 months ago

Veru to Participate in the Virtual BTIG Obesity Health Forum

Muscle-sparing obesity drug safe for Phase 3 trial, Veru says

BioPharma Dive

6 months ago

Muscle-sparing obesity drug safe for Phase 3 trial, Veru says

Veru Reports Positive Safety Results from Phase 2b QUALITY Study: Enobosarm Added to Semaglutide Led to Greater Fat Loss, Preservation of Muscle, and Fewer Gastrointestinal Side Effects Compared to Semaglutide Alone

GlobeNewswire

6 months ago

Veru Reports Positive Safety Results from Phase 2b QUALITY Study: Enobosarm Added to Semaglutide Led to Greater Fat Loss, Preservation of Muscle, and Fewer Gastrointestinal Side Effects Compared to Semaglutide Alone

Veru Inc (VERU) Q2 2025 Earnings Call Highlights: Promising Clinical Results Amid Financial ...

GuruFocus.com

6 months ago

Veru Inc (VERU) Q2 2025 Earnings Call Highlights: Promising Clinical Results Amid Financial ...

Veru Participates in a Virtual Investor KOL Connect Segment

GlobeNewswire

6 months ago

Veru Participates in a Virtual Investor KOL Connect Segment

Veru Reports Fiscal 2025 Second Quarter Financial Results and Clinical Program Progress

GlobeNewswire

6 months ago

Veru Reports Fiscal 2025 Second Quarter Financial Results and Clinical Program Progress

Veru Inc (VERU) Q2 2025 Earnings Report Preview: What To Look For

GuruFocus.com

6 months ago

Veru Inc (VERU) Q2 2025 Earnings Report Preview: What To Look For

Veru to Report Fiscal 2025 Second Quarter Financial Results on May 8

GlobeNewswire

7 months ago

Veru to Report Fiscal 2025 Second Quarter Financial Results on May 8

Veru to Present at the 2nd Annual GLP-1-Based Therapeutics Summit

GlobeNewswire

7 months ago

Veru to Present at the 2nd Annual GLP-1-Based Therapeutics Summit

Compass Therapeutics And 2 More Compelling Penny Stocks

Simply Wall St.

8 months ago

Compass Therapeutics And 2 More Compelling Penny Stocks

Veru to Participate in Fireside Chat at the Jones Healthcare and Technology Innovation Conference

GlobeNewswire

8 months ago

Veru to Participate in Fireside Chat at the Jones Healthcare and Technology Innovation Conference

Here's Why Veru (VERU) Looks Ripe for Bottom Fishing

Zacks

8 months ago

Here's Why Veru (VERU) Looks Ripe for Bottom Fishing

Down -9.23% in 4 Weeks, Here's Why Veru (VERU) Looks Ripe for a Turnaround

Zacks

9 months ago

Down -9.23% in 4 Weeks, Here's Why Veru (VERU) Looks Ripe for a Turnaround

3 US Penny Stocks With Market Caps Under $300M To Consider

Simply Wall St.

9 months ago

3 US Penny Stocks With Market Caps Under $300M To Consider

Veru Inc (VERU) Q1 2025 Earnings Call Highlights: Strategic Shifts and Clinical Progress Amid ...

GuruFocus.com

9 months ago

Veru Inc (VERU) Q1 2025 Earnings Call Highlights: Strategic Shifts and Clinical Progress Amid ...

Veru Reports Fiscal 2025 First Quarter Financial Results and Clinical Program Progress

GlobeNewswire

9 months ago

Veru Reports Fiscal 2025 First Quarter Financial Results and Clinical Program Progress

Veru Inc (VERU) Q1 2025 Earnings Report Preview: What To Expect

GuruFocus.com

9 months ago

Veru Inc (VERU) Q1 2025 Earnings Report Preview: What To Expect

Veru to Report Fiscal 2025 First Quarter Financial Results on February 13, 2025

GlobeNewswire

10 months ago

Veru to Report Fiscal 2025 First Quarter Financial Results on February 13, 2025

Veru to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

GlobeNewswire

10 months ago

Veru to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

Muscle-building drug improves body composition in obesity trial, Veru says

BioPharma Dive

10 months ago

Muscle-building drug improves body composition in obesity trial, Veru says

Veru Announces Positive Topline Data from Phase 2b QUALITY Clinical Study: Enobosarm Preserved Lean Mass in Patients Receiving WEGOVY® (Semaglutide) for Weight Reduction

GlobeNewswire

10 months ago

Veru Announces Positive Topline Data from Phase 2b QUALITY Clinical Study: Enobosarm Preserved Lean Mass in Patients Receiving WEGOVY® (Semaglutide) for Weight Reduction

What Makes Veru Inc. (VERU) a Strong Momentum Stock: Buy Now?

Zacks

10 months ago

What Makes Veru Inc. (VERU) a Strong Momentum Stock: Buy Now?

3 US Penny Stocks With Market Caps Under $200M To Consider

Simply Wall St.

10 months ago

3 US Penny Stocks With Market Caps Under $200M To Consider

Veru Sells FC2 Condom Business For $18 Million, Focuses On Biopharma Pipeline

Benzinga

a year ago

Veru Sells FC2 Condom Business For $18 Million, Focuses On Biopharma Pipeline

MT Newswires

a year ago

Veru Sells Female Condom Business to Riva Ridge Capital for $18 Million

Veru Announces the Sale of the FC2 Female Condom® (Internal Condom) Business

GlobeNewswire

a year ago

Veru Announces the Sale of the FC2 Female Condom® (Internal Condom) Business

Veru Inc. (VERU) Reports Q4 Loss, Tops Revenue Estimates

Zacks

a year ago

Veru Inc. (VERU) Reports Q4 Loss, Tops Revenue Estimates

US Penny Stocks To Consider In December 2024

Simply Wall St.

a year ago

US Penny Stocks To Consider In December 2024

The past three years for Veru (NASDAQ:VERU) investors has not been profitable

Simply Wall St.

a year ago

The past three years for Veru (NASDAQ:VERU) investors has not been profitable

Veru to Present at the 17th International Conference of the Society on Sarcopenia, Cachexia, & Wasting Disorders

GlobeNewswire

a year ago

Veru to Present at the 17th International Conference of the Society on Sarcopenia, Cachexia, & Wasting Disorders

Veru Announces Meta-analysis of Body Composition Data from Older Patients with Obesity which Supports Potential for Enobosarm to Optimize Weight Loss at ObesityWeek

GlobeNewswire

a year ago

Veru Announces Meta-analysis of Body Composition Data from Older Patients with Obesity which Supports Potential for Enobosarm to Optimize Weight Loss at ObesityWeek

Veru to Present at ObesityWeek: Meta-Analysis of 4 Previous Randomized Clinical Trials that Support the Potential of Enobosarm to Optimize Weight Loss

GlobeNewswire

a year ago

Veru to Present at ObesityWeek: Meta-Analysis of 4 Previous Randomized Clinical Trials that Support the Potential of Enobosarm to Optimize Weight Loss

Veru to Deliver Keynote Presentation on the Scientific Support for Enobosarm in Combination with GLP-1 Receptor Agonist to Preserve Muscle for Higher Quality Weight Loss at the 4th Edition of the World Obesity and Weight Management Congress

GlobeNewswire

a year ago

Veru to Deliver Keynote Presentation on the Scientific Support for Enobosarm in Combination with GLP-1 Receptor Agonist to Preserve Muscle for Higher Quality Weight Loss at the 4th Edition of the World Obesity and Weight Management Congress

Veru Inc (VERU) Q3 2024 Earnings Call Highlights: Strategic Cost Management and Revenue Growth ...

GuruFocus.com

a year ago

Veru Inc (VERU) Q3 2024 Earnings Call Highlights: Strategic Cost Management and Revenue Growth ...

Veru to Present at the 2024 Cantor Global Healthcare Conference

GlobeNewswire

a year ago

Veru to Present at the 2024 Cantor Global Healthcare Conference

Earnings Beat: Veru Inc. (NASDAQ:VERU) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts

Simply Wall St.

a year ago

Earnings Beat: Veru Inc. (NASDAQ:VERU) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts

Veru Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.

a year ago

Veru Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Veru Inc. (VERU) Reports Q3 Loss, Tops Revenue Estimates

Zacks

a year ago

Veru Inc. (VERU) Reports Q3 Loss, Tops Revenue Estimates

Veru Reaches Full Enrollment for Phase 2b QUALITY Clinical Study of Enobosarm for Obesity and Reports Fiscal 2024 Third Quarter Financial Results

GlobeNewswire

a year ago

Veru Reaches Full Enrollment for Phase 2b QUALITY Clinical Study of Enobosarm for Obesity and Reports Fiscal 2024 Third Quarter Financial Results

Veru to Report Fiscal 2024 Third Quarter Financial Results on August 8, 2024

GlobeNewswire

a year ago

Veru to Report Fiscal 2024 Third Quarter Financial Results on August 8, 2024

Veru to Participate in the BTIG Virtual Biotechnology Conference

GlobeNewswire

a year ago

Veru to Participate in the BTIG Virtual Biotechnology Conference

Veru to Participate in the Leerink Therapeutics Forum: I&I and Metabolism

GlobeNewswire

a year ago

Veru to Participate in the Leerink Therapeutics Forum: I&I and Metabolism

Veru (NASDAQ:VERU) investors are sitting on a loss of 89% if they invested three years ago

Simply Wall St.

a year ago

Veru (NASDAQ:VERU) investors are sitting on a loss of 89% if they invested three years ago

Veru Announces Safety and Body Composition Data from Two Late-Breaker Presentations at the American Diabetes Association's 84th Scientific Sessions

GlobeNewswire

a year ago

Veru Announces Safety and Body Composition Data from Two Late-Breaker Presentations at the American Diabetes Association's 84th Scientific Sessions

Veru Adjourns 2024 Annual Meeting of Shareholders to June 27, 2024

GlobeNewswire

a year ago

Veru Adjourns 2024 Annual Meeting of Shareholders to June 27, 2024

Veru Reminds Shareholders to Vote in Advance of Tomorrow’s Deadline for 2024 Annual Meeting of Shareholders

GlobeNewswire

a year ago

Veru Reminds Shareholders to Vote in Advance of Tomorrow’s Deadline for 2024 Annual Meeting of Shareholders

Veru to Present at the American Diabetes Association's 84th Scientific Sessions

GlobeNewswire

a year ago

Veru to Present at the American Diabetes Association's 84th Scientific Sessions

Individual investors account for 48% of Veru Inc.'s (NASDAQ:VERU) ownership, while institutions account for 25%

Simply Wall St.

a year ago

Individual investors account for 48% of Veru Inc.'s (NASDAQ:VERU) ownership, while institutions account for 25%

Veru to Present at the Jefferies Global Healthcare Conference

GlobeNewswire

a year ago

Veru to Present at the Jefferies Global Healthcare Conference

Veru Announces Steven B. Heymsfield M.D. as the Principal Investigator for its Enobosarm Phase 2b Clinical Trial for High Quality Weight Loss

GlobeNewswire

2 years ago

Veru Announces Steven B. Heymsfield M.D. as the Principal Investigator for its Enobosarm Phase 2b Clinical Trial for High Quality Weight Loss

Veru Announces Mitchell Steiner as Keynote Speaker at Biomed Israel 2024: The 22nd National Life Science & Technology Week

GlobeNewswire

2 years ago

Veru Announces Mitchell Steiner as Keynote Speaker at Biomed Israel 2024: The 22nd National Life Science & Technology Week

GuruFocus.com

2 years ago

Veru Inc (VERU) Q2 2024 Earnings Call Transcript Highlights: Strategic Focus and Financial Recovery

GuruFocus.com

2 years ago

Veru Inc. (VERU) Fiscal 2024 Q2 Earnings: Clinical Advances Amid Financial Strains

Veru Reports Fiscal 2024 Second Quarter Financial Results and Progress of its Enobosarm High Quality Weight Loss Clinical Program

GlobeNewswire

2 years ago

Veru Reports Fiscal 2024 Second Quarter Financial Results and Progress of its Enobosarm High Quality Weight Loss Clinical Program

Veru to Present at the GLP-1 Based Therapeutics Summit

GlobeNewswire

2 years ago

Veru to Present at the GLP-1 Based Therapeutics Summit

Veru to Report Fiscal 2024 Second Quarter Financial Results on May 8, 2024

GlobeNewswire

2 years ago

Veru to Report Fiscal 2024 Second Quarter Financial Results on May 8, 2024

Veru Inc. (VERU) Just Flashed Golden Cross Signal: Do You Buy?

Zacks

2 years ago

Veru Inc. (VERU) Just Flashed Golden Cross Signal: Do You Buy?

Veru Enrolls First Patients in Phase 2b Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss

GlobeNewswire

2 years ago

Veru Enrolls First Patients in Phase 2b Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss

Veru to Present at the American Association of Clinical Endocrinology (AACE) 2024 Annual Meeting on May 9-11

GlobeNewswire

2 years ago

Veru to Present at the American Association of Clinical Endocrinology (AACE) 2024 Annual Meeting on May 9-11

What Makes Veru (VERU) a New Buy Stock

Zacks

2 years ago

What Makes Veru (VERU) a New Buy Stock

Veru Announces Date of 2024 Annual Meeting of Shareholders

GlobeNewswire

2 years ago

Veru Announces Date of 2024 Annual Meeting of Shareholders

Veru Reschedules Annual Meeting of Shareholders

GlobeNewswire

2 years ago

Veru Reschedules Annual Meeting of Shareholders

Veru Announces the Appointment of Louis Aronne MD as Chief Medical Advisor for its Enobosarm Program for High Quality Weight Loss

GlobeNewswire

2 years ago

Veru Announces the Appointment of Louis Aronne MD as Chief Medical Advisor for its Enobosarm Program for High Quality Weight Loss

Veru Announces Notification from Nasdaq Related to Delayed Quarterly Report on Form 10-Q

GlobeNewswire

2 years ago

Veru Announces Notification from Nasdaq Related to Delayed Quarterly Report on Form 10-Q

Veru Announces New Scientific Advisory Board for its Enobosarm Program for High Quality Weight Loss

GlobeNewswire

2 years ago

Veru Announces New Scientific Advisory Board for its Enobosarm Program for High Quality Weight Loss

After Plunging -15.61% in 4 Weeks, Here's Why the Trend Might Reverse for Veru Inc. (VERU)

Zacks

2 years ago

After Plunging -15.61% in 4 Weeks, Here's Why the Trend Might Reverse for Veru Inc. (VERU)

Veru Inc. (NASDAQ:VERU) Q1 2024 Earnings Call Transcript

Insider Monkey

2 years ago

Veru Inc. (NASDAQ:VERU) Q1 2024 Earnings Call Transcript

Thomson Reuters StreetEvents

2 years ago

Q1 2024 Veru Inc Earnings Call

Veru Reports Fiscal 2024 First Quarter Financial Highlights

GlobeNewswire

2 years ago

Veru Reports Fiscal 2024 First Quarter Financial Highlights

Veru Announces FDA Clearance of IND Application to Initiate Phase 2b Clinical Trial with Enobosarm to Treat Muscle Loss Associated with Weight Loss Drugs

GlobeNewswire

2 years ago

Veru Announces FDA Clearance of IND Application to Initiate Phase 2b Clinical Trial with Enobosarm to Treat Muscle Loss Associated with Weight Loss Drugs

Charles River (CRL) to Report Q4 Earnings: What's in Store?

Zacks

2 years ago

Charles River (CRL) to Report Q4 Earnings: What's in Store?

Veru Inc. (VERU) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

Zacks

2 years ago

Veru Inc. (VERU) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

Veru to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

GlobeNewswire

2 years ago

Veru to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

GuruFocus.com

2 years ago

Provident Financial Holdings Inc Reports Mixed Fiscal Q2 Results Amid Economic Uncertainty

Provident Financial (PROV) Surpasses Q2 Earnings Estimates

Zacks

2 years ago

Provident Financial (PROV) Surpasses Q2 Earnings Estimates

OP Bancorp Full Year 2023 Earnings: EPS Misses Expectations

Simply Wall St.

2 years ago

OP Bancorp Full Year 2023 Earnings: EPS Misses Expectations

BK Technologies Receives Purchase Order for BKR 9000 Radios from the Arkansas Department of Agriculture Forestry Division

ACCESSWIRE

2 years ago

BK Technologies Receives Purchase Order for BKR 9000 Radios from the Arkansas Department of Agriculture Forestry Division

Veru to Report Fiscal 2024 First Quarter Financial Results on February 8, 2024

GlobeNewswire

2 years ago

Veru to Report Fiscal 2024 First Quarter Financial Results on February 8, 2024

SurgePays Announces Closing of $15 Million Public Offering

GlobeNewswire

2 years ago

SurgePays Announces Closing of $15 Million Public Offering

Vaxxinity & UCF to Collaborate on Space Medicine Research

Exec Edge

2 years ago

Vaxxinity & UCF to Collaborate on Space Medicine Research

Nine Energy Service Announces Timing of Fourth Quarter and Full Year 2023 Earnings Release and Conference Call

Business Wire

2 years ago

Nine Energy Service Announces Timing of Fourth Quarter and Full Year 2023 Earnings Release and Conference Call

Chijet Motor Company, Inc. Signs Strategic Agreement to Improve Automotive Cybersecurity

GlobeNewswire

2 years ago

Chijet Motor Company, Inc. Signs Strategic Agreement to Improve Automotive Cybersecurity

Veru Submits IND Application to FDA for the Development of Enobosarm to Prevent Muscle Loss While Augmenting Fat Loss in Combination with GLP-1 Drugs for Weight Loss

GlobeNewswire

2 years ago

Veru Submits IND Application to FDA for the Development of Enobosarm to Prevent Muscle Loss While Augmenting Fat Loss in Combination with GLP-1 Drugs for Weight Loss

Innovative Solutions and Support, Inc. (NASDAQ:ISSC) Q4 2023 Earnings Call Transcript

Insider Monkey

2 years ago

Innovative Solutions and Support, Inc. (NASDAQ:ISSC) Q4 2023 Earnings Call Transcript

Insider Sell: President and CEO French Glendon E. III Sells 10,000 Shares of Pulmonx Corp (LUNG)

GuruFocus.com

2 years ago

Insider Sell: President and CEO French Glendon E. III Sells 10,000 Shares of Pulmonx Corp (LUNG)

Asure Software (ASUR) Enhances Payroll With SAP Integration

Zacks

2 years ago

Asure Software (ASUR) Enhances Payroll With SAP Integration

The ONE Group Hospitality, Inc. Opens STK Boston

Business Wire

2 years ago

The ONE Group Hospitality, Inc. Opens STK Boston

Veru to Host Investor Call on January 4th, 2024 to Discuss Recent Financing and Strategy to Prioritize the Development of Enobosarm as a Combination Treatment to Prevent Muscle Loss and Augment Fat Loss Associated with Weight Loss GLP-1 Drugs

GlobeNewswire

2 years ago

Veru to Host Investor Call on January 4th, 2024 to Discuss Recent Financing and Strategy to Prioritize the Development of Enobosarm as a Combination Treatment to Prevent Muscle Loss and Augment Fat Loss Associated with Weight Loss GLP-1 Drugs

The Price Is Right For Veru Inc. (NASDAQ:VERU) Even After Diving 29%

Simply Wall St.

2 years ago

The Price Is Right For Veru Inc. (NASDAQ:VERU) Even After Diving 29%

Further Upside For Maiden Holdings, Ltd. (NASDAQ:MHLD) Shares Could Introduce Price Risks After 38% Bounce

Simply Wall St.

2 years ago

Further Upside For Maiden Holdings, Ltd. (NASDAQ:MHLD) Shares Could Introduce Price Risks After 38% Bounce

Veru Announces Pricing of Public Offering of Common Stock

GlobeNewswire

2 years ago

Veru Announces Pricing of Public Offering of Common Stock

FS Bancorp, Inc. (NASDAQ:FSBW) is a favorite amongst institutional investors who own 67%

Simply Wall St.

2 years ago

FS Bancorp, Inc. (NASDAQ:FSBW) is a favorite amongst institutional investors who own 67%

Share on Social Networks: